±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1127  |  »Ø¸´: 9
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßzhaoyongqiangÔö¼Ó½ð±Ò 1.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


[×ÊÔ´] Reversed Phase Chromatography(ÍâÎÄÊé¼®)

ÏÂÔØµØÖ·http://www.namipan.com/d/Reverse ... 3e9f7057b6b0c7e0800

Contents
1. Introduction ..............................................................................................5
Theory of reversed phase chromatography ...............................................6
The matrix ................................................................................................9
The ligands ............................................................................................. 11
Resolution in reversed phase chromatography ........................................ 13
Resolution .............................................................................................. 13
Capacity factor ....................................................................................... 14
Efficiency ................................................................................................ 15
Selectivity ................................................................................................ 17
Binding capacity ..................................................................................... 18
Critical parameters in reversed phase chromatography........................... 19
Column length ...................................................................................19
Flow rate ............................................................................................19
Temperature ....................................................................................... 20
Mobile phase ..................................................................................... 20
Organic solvent .................................................................................. 20
Ion suppression .................................................................................. 21
Ion pairing agents .............................................................................. 22
Gradient elution ................................................................................. 23
Mode of use ............................................................................................24
Desalting ............................................................................................24
High resolution separations ............................................................... 25
Large scale preparative purification ................................................... 25
Stages in a purification scheme .......................................................... 26
Capture .............................................................................................. 26
Intermediate stages .............................................................................27
Polishing ............................................................................................27
2. Product Guide .........................................................................................29
SOURCE™ RPC ..................................................................................... 30
Product description ............................................................................ 30
High chemical stability ...................................................................... 32
Excellent flow/pressure characteristics ................................................ 34
High capacity ..................................................................................... 35
Availability ........................................................................................ 36
¦ÌRPC C2/C18 .........................................................................................37
Product description ............................................................................ 37
Chemical and physical stability .......................................................... 38
Flow/pressure characteristics ..............................................................38
Capacity ............................................................................................38
Availability ........................................................................................ 39
Sephasil™ Protein/Sephasil Peptide ......................................................... 39
Product description ............................................................................ 39
Chemical and physical stability .......................................................... 40
Flow/pressure characteristics ..............................................................40
Availability ........................................................................................ 40
3. Methods ................................................................................................. 41
Choice of separation medium .................................................................41
Unique requirements of the application .............................................. 41
Resolution .......................................................................................... 41
Scale of the purification ..................................................................... 42
Mobile phase conditions ....................................................................42
Throughput and scaleability ..............................................................42
Molecular weight of the sample components ......................................42
Hydrophobicity of the sample components ........................................ 43
Class of sample components ..............................................................43
Choice of mobile phase ........................................................................... 44
The organic solvent ............................................................................ 44
pH .....................................................................................................46
Ion pairing agents .............................................................................. 47
Sample preparation................................................................................. 49
Mobile phase preparation .......................................................................50
Storage of mobile phase ..................................................................... 50
Solvent disposal ................................................................................. 50
Detection ................................................................................................ 51
Ghosting ............................................................................................51
Mobile phase balancing ..................................................................... 51
Column conditioning .............................................................................. 52
Elution conditions ...................................................................................53
Column re-equilibration ......................................................................... 55
Column cleaning ..................................................................................... 55
Column storage ......................................................................................56
4. Applications............................................................................................57
Designing a biochemical purification ...................................................... 57
Naturally occurring peptides and proteins .............................................. 58
Purification of platelet-derived growth factor (PDGF) ........................ 59
Trace enrichment ............................................................................... 59
Purification of cholecystokinin-58 (CCK-58) from pig intestine ......... 60
Recombinant peptides and proteins ........................................................62
Process purification of inclusion bodies .............................................. 63
Purification of recombinant human epidermal growth factor ............. 63
Chemically synthesised peptides..............................................................65
Purification of a phosphorylated PDGF a-receptor derived peptide .... 65
Structural characterisation of a 165 kDa protein ............................... 66
Protein fragments from enzyme digests ................................................... 66
Protein characterisation at the micro-scale .........................................66
Protein identification by LC-MS ......................................................... 69
Chemically synthesised oligonucleotides ................................................. 70
5. Fault finding chart .................................................................................. 72
6. References ...............................................................................................81
7. Ordering information .............................................................................84

[ Last edited by zhaoyongqiang on 2008-3-17 at 12:07 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


Ö§³Öһϣ¡
8Â¥2008-03-19 14:50:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


¡¾ÆÀ¼Û¡¿  ¡ï¡ï¡ï¡ï¡ï (ÎåÐǼ¶,ÓÅÐãÍÆ¼ö)

¼ûÊéÆÀÌû¡­¡­
4Â¥2008-03-17 12:03:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

weifengnit

ľ³æ (ÕýʽдÊÖ)


Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£
5Â¥2008-03-17 13:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhaoyongqiang

½ð³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
Originally posted by ruyibaobei at 2008-3-17 12:34:
ºÃ¶«¶«

¼ûÊéÆÀÌû¡­¡­
7Â¥2008-03-18 15:35:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-03-17 15:01   »Ø¸´  
ÒýÓûØÌû:
Originally posted by weifengnit at 2008-3-17 13:48: Õâ¸öÒÔǰÌû¹ýÁ˵쬯äʵ¾ÍÊÇÒ»¸ö¹«Ë¾µÄ²úƷ˵Ã÷Êé¡£ÔÚ˵Ã÷ÊéÇ°Ãæ¼òµ¥µØ½éÉÜÁËһϷ´ÏàÉ«Æ×£¬¶øÕâЩ֪ʶ¶¼ÊÇ´ó¼ÒÊìϤµÄ¡£

¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 303Çóµ÷¼Á +10 DLkz1314. 2026-03-30 10/500 2026-04-03 18:03 by Jimmyandyou
[¿¼ÑÐ] ѧ˶»úе¹¤³Ì303Çóµ÷¼Á +6 ÎÞÃûËùÒÔ½ÐÎâÃ÷ 2026-03-30 7/350 2026-04-03 16:48 by asdfzly
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +13 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 13/650 2026-04-03 16:08 by ŶŶ123
[¿¼ÑÐ] »¯Ñ§µ÷¼Á +9 °¬Ö¾ºã 2026-04-03 10/500 2026-04-03 15:51 by Çç¿Õ210210
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +5 ´ºÈÕÀ´ÐÅ- 2026-04-03 5/250 2026-04-03 15:01 by buqi613
[¿¼ÑÐ] 282Çóµ÷¼Á ²»Ìôרҵ ÇóÊÕÁô +7 Yam. 2026-03-30 8/400 2026-04-03 14:12 by zhangdingwa
[¿¼ÑÐ] Çóµ÷¼Á +9 akdhjs 2026-03-31 11/550 2026-04-03 13:32 by akdhjs
[¿¼ÑÐ] ±§Ç¸ +5 ÌïºéÓÐ 2026-03-30 5/250 2026-04-03 10:24 by linyelide
[¿¼ÑÐ] Ò»Ö¾Ô¸Éî´ó085601²ÄÁϹ¤³Ìרҵ£¨×¨Ë¶£©300·Ö¿ÉÒÔµ÷¼ÁÈ¥ÄÄ +8 10160315 2026-04-02 8/400 2026-04-03 09:36 by hypershenger
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº²ÄÁÏÓ뻯¹¤×¨Ë¶£¬360·ÖÇóµ÷¼Á +4 ²»Ô¸Í¸Â¶ÐÕÃûµÄË 2026-04-02 4/200 2026-04-03 09:29 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] ²ÄÁÏ340·Öµ÷¼Á +7 ÏÄÒ¹Íí·ç_long 2026-04-02 9/450 2026-04-02 21:20 by dongzh2009
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-04-02 5/250 2026-04-02 21:16 by ÍÃͻͻͻ£¬
[¿¼ÑÐ] 271Çóµ÷¼Á +15 ÀÕ²¼ÀÊ@ 2026-03-31 20/1000 2026-04-02 11:24 by Sammy2
[¿¼ÑÐ] 270µ÷¼Á +7 maxjxbsk 2026-04-02 7/350 2026-04-02 09:50 by yulian1987
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õ´óѧ¼ÆËã»ú¿ÆÑ§Óë¼¼Êõѧ˶£¬331·ÖÇóµ÷¼Á +5 ½¯²ýÅôqtj 2026-04-01 5/250 2026-04-02 08:10 by fxue1114
[¿¼ÑÐ] 265Çóµ÷¼Á +11 yelck 2026-04-01 12/600 2026-04-01 19:12 by 549790059
[¿¼ÑÐ] »¯Ñ§0703 µ÷¼Á 306·Ö Ò»Ö¾Ô¸211 +12 26ÒªÉϰ¶ 2026-03-28 12/600 2026-04-01 11:10 by chemdavid
[¿¼ÑÐ] 254²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +3 º²¶¬ÁÖéª 2026-03-30 4/200 2026-03-31 17:53 by yishunmin
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã½­´óѧ¹¤¿Æ¶¯Á¦¹¤³Ì370,ÊýÒ»121,רҵ¿Î135£¬ÏÖÔÚÄÜÈ¥ÄÄÀï +3 080700µ÷¼Á 2026-03-30 4/200 2026-03-31 12:00 by KLMY666
[¿¼ÑÐ] 370Çóµ÷¼Á +3 080700µ÷¼Á 2026-03-30 3/150 2026-03-31 01:09 by A_Zhe
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û